Related Experiment Videos
Hereditary cancer and its clinical implications: a view
W Den Otter1, J W Koten, B J Van der Vegt
1Department of Pathology, Academisch Ziekenhuis, Utrecht, The Netherlands.
Anticancer Research
|March 1, 1990
Summary
Hereditary cancers result from inherited mutations in tumor suppressor genes, increasing cancer risk by 10,000 to 100,000 times. Early detection through screening for primary and secondary tumors is crucial for managing hereditary cancer.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Hereditary cancers arise from inherited mutations in anti-oncogenes (tumor suppressor genes).
- These inherited mutations predispose individuals to cancer by requiring fewer additional somatic mutations for tumor development.
Purpose of the Study:
- To explain the significantly increased cancer risk in hereditary cancer syndromes.
- To highlight clinical recognition patterns of hereditary cancers.
- To recommend screening strategies for hereditary cancer patients and families.
Main Methods:
- Review of existing literature and established genetic models of cancer.
- Analysis of mutation accumulation in hereditary versus sporadic cancers.
- Clinical observation of tumor development patterns in hereditary cancer syndromes.
Main Results:
- Inherited mutations in tumor suppressor genes increase cancer risk by 10^4-10^5 fold.
- This enhanced risk leads to earlier onset, multifocal, and bilateral tumors, as well as cancer family syndromes and second primary malignancies.
- Second primary malignancies are not due to metastasis but arise independently.
Conclusions:
- Hereditary cancer risk is significantly amplified due to inherited anti-oncogene defects.
- Clinical features like early onset, multiple tumors, and family history aid in recognizing hereditary cancer.
- Screening for both first and second primary tumors is recommended for affected families, with careful treatment to prevent further mutations.